23andMe’s Recent Research Collaborations

This week 23andMe announced a collaboration with Pfizer Inc, allowing researchers with the drug maker to leverage 23andMe’s unique platform to conduct genome-wide associations studies, surveys and clinical trial recruitment.

The news follows a collaboration begun over the summer between 23andMe and Pfizer to enroll 10,000 people in a study to explore the genetic factors associated with the onset, progression, severity and response to treatment for Inflammatory Bowel Disease.

The collaboration with Pfizer — as well as work with academic researchers and other companies such as Genentech, Reset Therapeutics and others — is part of an effort by 23andMe to offer qualified and approved scientists outside of 23andMe a chance to leverage our unique research platform for discovery.

For more about 23andMe’s collaborations see our CEO’s interview on CNBC.






  • Ahmad

    What 23andMe is achieving and planning to achieve in the future is remarkable! .. I am an academic researcher, can we be part of this research community? Can we contribute our own research in Genetics to 23andMe?

    • 23blog

      Thanks Ahmad,
      The work with Genentech is specifically focused on individuals with Parkinson’s, who are in our Parkinson’s Research and requires an additional layer of consent. However simply consenting to research as a 23andMe customer does power our research more broadly.

  • 23blog

    Ahmad,
    We do not currently ship to Kuwait. Here is a link to the list of countries to which we ship kits (https://customercare.23andme.com/hc/en-us/articles/202907910-What-countries-do-you-ship-to-)

Return to top